APA (7th ed.) Citation

E, B., C, K., S, M., A, S., F, C., S, C., . . . F, M. (2023). Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene therapy, 30(3-4), 245. https://doi.org/10.1038/s41434-020-00218-6

Chicago Style (17th ed.) Citation

E, Barbon, et al. "Development of a Dual Hybrid AAV Vector for Endothelial-targeted Expression of Von Willebrand Factor." Gene Therapy 30, no. 3-4 (2023): 245. https://doi.org/10.1038/s41434-020-00218-6.

MLA (9th ed.) Citation

E, Barbon, et al. "Development of a Dual Hybrid AAV Vector for Endothelial-targeted Expression of Von Willebrand Factor." Gene Therapy, vol. 30, no. 3-4, 2023, p. 245, https://doi.org/10.1038/s41434-020-00218-6.